↓ Skip to main content

Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia

Overview of attention for article published in BMC Pulmonary Medicine, November 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

twitter
15 X users

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
15 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia
Published in
BMC Pulmonary Medicine, November 2022
DOI 10.1186/s12890-022-02246-x
Pubmed ID
Authors

Carlos A. Torres-Duque, Jaime Ocampo-Gómez, Mauricio Morales Castillo, Diana Cano-Rosales, Ángela Giraldo-Montoya, Freddy Rodríguez, Isabel Palacios-Ortega, Mauricio Durán-Silva, Humberto Reynales, Elizabeth García

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 15 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 15 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 13%
Student > Bachelor 1 7%
Student > Ph. D. Student 1 7%
Professor 1 7%
Unknown 10 67%
Readers by discipline Count As %
Medicine and Dentistry 5 33%
Biochemistry, Genetics and Molecular Biology 2 13%
Immunology and Microbiology 1 7%
Unknown 7 47%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 December 2022.
All research outputs
#4,093,805
of 25,000,733 outputs
Outputs from BMC Pulmonary Medicine
#302
of 2,215 outputs
Outputs of similar age
#80,956
of 484,978 outputs
Outputs of similar age from BMC Pulmonary Medicine
#9
of 82 outputs
Altmetric has tracked 25,000,733 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,215 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.6. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 484,978 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 82 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.